Authority-expert buyers need more than a product overview. They need to see how intended use, validation, interoperability, cybersecurity, clinical workflow, service continuity, and lifecycle economics fit together before a technology enters the capital review process.
Evidence packages may include modality-specific conformance statements, phantom quality routines, dose dashboard references, DICOM SOP class support, DICOMweb behavior, VNA compatibility, and workflow diagrams for critical result notification. This lets radiology leaders compare clinical capability and operational risk in a structured way.
Diagnostic laboratory review usually requires precision studies, linearity, calibration interval, lot traceability, CAP proficiency testing alignment, Westgard rule handling, reportable range, LIS integration, and sample handling details. The evidence must help laboratory directors understand throughput and analytical variation together.
Patient monitoring and remote care evidence focuses on observation frequency, waveform export, alarm priority behavior, FHIR or HL7 mapping, endpoint hardening, mTLS, SBOM review, role-based access, and escalation patterns when network or device events occur.
Committees increasingly ask for uptime assumptions, MTBF and MTTR references, preventive maintenance schedules, loaner policies, parts positioning, cybersecurity patch windows, end-of-life timing, decommissioning records, and training plans that prevent technology from becoming operational debt.
No single architecture wins every case. The notes below frame the live debates so review teams can document the trade-off explicitly rather than leaving it implicit in the RFP.
VNA case: Freedom to swap viewers and modality vendors without data migration, lower long-term storage cost, easier consolidation of radiology, cardiology, and pathology images, and alignment with DICOMweb plus FHIR ImagingStudy resources.
Integrated PACS case: Deeper workflow integration with worklists, dictation, and AI tools, single support contract, faster deployment, and tighter coupling with modality performance optimizations from the same vendor.
Siemens Healthineers documentation can be reviewed against either architecture; conformance statements identify which DICOM SOP classes, DICOMweb endpoints, and FHIR resources the device supports so VNA migration risk and integrated-suite dependencies remain visible.
Core lab case: Higher automation, superior analytical performance and QC traceability, lower cost per test at scale, simpler CAP / CLIA accreditation oversight, and broader test menu available overnight.
POCT case: Actionable results in minutes at the bedside, reduced length of stay and door-to-balloon times, fewer pre-analytical errors from transport, and clinical decision support at the care moment.
Most health systems run a hybrid model. Diagnostic packets include precision data, lot stability, calibration intervals, LIS middleware behavior, and connectivity expectations so laboratory directors can defend a hybrid architecture without overstating either side.
Honest scope statements help committees avoid over-deploying technology. Examples documented in clinical evidence packets include:
Use the request route to identify the documentation needed for your facility: 510(k) summary, CE MDR or IVDR technical file pathway, DICOM conformance statement, HL7/FHIR capability summary, cybersecurity SBOM, clinical application guide, PM schedule, service contract tiers, or implementation planning checklist. A focused packet reduces committee delays and avoids asking clinical teams to compare inconsistent information.
Request Evidence Packet